Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 Feb;48(2):115–119. doi: 10.1136/jcp.48.2.115

Specific increase in interleukin-8 concentrations in dialysis fluid of patients with peritonitis receiving continuous ambulatory peritoneal dialysis.

Y C Ko 1, N Mukaida 1, T Kasahara 1, S Muto 1, K Matsushima 1, E Kusano 1, Y Asano 1, Y Itoh 1, Y Yamagishi 1, T Kawai 1
PMCID: PMC502373  PMID: 7745108

Abstract

AIMS--To evaluate the influence of interleukin-8 (IL-8) and other inflammatory cytokines (IL-6, IL-1 beta and tumour necrosis factor alpha (TNF alpha)) on the occurrence of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD). METHODS--The study population comprised 12 patients with peritonitis, 33 without peritonitis, all undergoing CAPD, and five patients undergoing peritoneal catheter implantation. Cytokine concentrations in dialysis fluid were determined by immunoassay and their values compared. RESULTS--Concentrations of both IL-8 (median 147 pg/ml, range 20-2273 pg/ml; n = 12) and IL-6 (median 1120 pg/ml, range 96-10,600 pg/ml) were substantially elevated, while the IL-1 beta concentration was lower and TNF alpha was not detectable in patients at diagnosis. The IL-6 concentration was also elevated in patients undergoing catheter implantation as well as in those with peritonitis. The IL-8 concentration, however, was elevated only upon infection. Intraperitoneal production of IL-8 was evident on determination of paired serum and dialysis fluid cytokine concentrations, and immunostaining of peritoneal cells with monoclonal anti-IL-8 antibody. CONCLUSIONS--These results suggest that determination of the IL-8 concentration in dialysis fluid maybe useful as a specific marker for following patients with peritonitis receiving CAPD.

Full text

PDF
115

Images in this article

117Image
on p.117

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagby G. J., Plessala K. J., Wilson L. A., Thompson J. J., Nelson S. Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis. J Infect Dis. 1991 Jan;163(1):83–88. doi: 10.1093/infdis/163.1.83. [DOI] [PubMed] [Google Scholar]
  2. Baggiolini M., Imboden P., Detmers P. Neutrophil activation and the effects of interleukin-8/neutrophil-activating peptide 1 (IL-8/NAP-1). Cytokines. 1992;4:1–17. [PubMed] [Google Scholar]
  3. Bazzoni F., Cassatella M. A., Rossi F., Ceska M., Dewald B., Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med. 1991 Mar 1;173(3):771–774. doi: 10.1084/jem.173.3.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Betjes M. G., Tuk C. W., Struijk D. G., Krediet R. T., Arisz L., Hart M., Beelen R. H. Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. J Infect Dis. 1993 Nov;168(5):1202–1210. doi: 10.1093/infdis/168.5.1202. [DOI] [PubMed] [Google Scholar]
  5. Betjes M. G., Tuk C. W., Struijk D. G., Krediet R. T., Arisz L., Hoefsmit E. C., Beelen R. H. Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study. Kidney Int. 1993 Mar;43(3):641–648. doi: 10.1038/ki.1993.93. [DOI] [PubMed] [Google Scholar]
  6. Bos H. J., Struijk D. G., Tuk C. W., de Veld J. C., Helmerhorst T. J., Hoefsmit E. C., Arisz L., Beelen R. H. Peritoneal dialysis induces a local sterile inflammatory state and the mesothelial cells in the effluent are related to the bacterial peritonitis incidence. Nephron. 1991;59(3):508–509. doi: 10.1159/000186623. [DOI] [PubMed] [Google Scholar]
  7. Brauner A., Hylander B., Wretlind B. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1993 Sep;22(3):430–435. doi: 10.1016/s0272-6386(12)70147-6. [DOI] [PubMed] [Google Scholar]
  8. Carozzi S., Nasini M. G., Schelotto C., Caviglia P. M., Cantaluppi A., Salit M., Lamperi S. Intraperitoneal therapy with interferon-alpha in CAPD patients with relapsing bacterial peritonitis. ASAIO Trans. 1989 Jul-Sep;35(3):421–423. doi: 10.1097/00002480-198907000-00080. [DOI] [PubMed] [Google Scholar]
  9. Cassatella M. A., Bazzoni F., Ceska M., Ferro I., Baggiolini M., Berton G. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. J Immunol. 1992 May 15;148(10):3216–3220. [PubMed] [Google Scholar]
  10. Cicco N. A., Lindemann A., Content J., Vandenbussche P., Lübbert M., Gauss J., Mertelsmann R., Herrmann F. Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood. 1990 May 15;75(10):2049–2052. [PubMed] [Google Scholar]
  11. Danhauer J. L., Mulac A., Eve I. L. Health care providers' and peers' impressions of elderly hearing aid wearers. Am J Otol. 1985 Mar;6(2):146–149. [PubMed] [Google Scholar]
  12. Davies S. J., Suassuna J., Ogg C. S., Cameron J. S. Activation of immunocompetent cells in the peritoneum of patients treated with CAPD. Kidney Int. 1989 Oct;36(4):661–668. doi: 10.1038/ki.1989.243. [DOI] [PubMed] [Google Scholar]
  13. DeForge L. E., Kenney J. S., Jones M. L., Warren J. S., Remick D. G. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J Immunol. 1992 Apr 1;148(7):2133–2141. [PubMed] [Google Scholar]
  14. Fieren M. W., Van den Bemd G. J., Bonta I. L. Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1 beta in vitro during infectious peritonitis. Eur J Clin Invest. 1990 Aug;20(4):453–457. doi: 10.1111/j.1365-2362.1990.tb01883.x. [DOI] [PubMed] [Google Scholar]
  15. Furuta R., Yamagishi J., Kotani H., Sakamoto F., Fukui T., Matsui Y., Sohmura Y., Yamada M., Yoshimura T., Larsen C. G. Production and characterization of recombinant human neutrophil chemotactic factor. J Biochem. 1989 Sep;106(3):436–441. doi: 10.1093/oxfordjournals.jbchem.a122870. [DOI] [PubMed] [Google Scholar]
  16. Goldman M., Vandenabeele P., Moulart J., Amraoui Z., Abramowicz D., Nortier J., Vanherweghem J. L., Fiers W. Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis. Nephron. 1990;56(3):277–280. doi: 10.1159/000186154. [DOI] [PubMed] [Google Scholar]
  17. Havell E. A., Sehgal P. B. Tumor necrosis factor-independent IL-6 production during murine listeriosis. J Immunol. 1991 Jan 15;146(2):756–761. [PubMed] [Google Scholar]
  18. Hirano T. The biology of interleukin-6. Chem Immunol. 1992;51:153–180. [PubMed] [Google Scholar]
  19. Ko Y. C., Mukaida N., Ishiyama S., Tokue A., Kawai T., Matsushima K., Kasahara T. Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect Immun. 1993 Apr;61(4):1307–1314. doi: 10.1128/iai.61.4.1307-1314.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ko Y., Mukaida N., Panyutich A., Voitenok N. N., Matsushima K., Kawai T., Kasahara T. A sensitive enzyme-linked immunosorbent assay for human interleukin-8. J Immunol Methods. 1992 May 18;149(2):227–235. doi: 10.1016/0022-1759(92)90254-q. [DOI] [PubMed] [Google Scholar]
  21. Lin C. Y., Ku W. L., Huang T. P. Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients. Am J Nephrol. 1990;10(5):368–373. doi: 10.1159/000168152. [DOI] [PubMed] [Google Scholar]
  22. Lin C. Y., Lin C. C., Huang T. P. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis. Nephron. 1993;63(4):404–408. doi: 10.1159/000187243. [DOI] [PubMed] [Google Scholar]
  23. Matsushima K., Baldwin E. T., Mukaida N. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem Immunol. 1992;51:236–265. [PubMed] [Google Scholar]
  24. Nakahama H., Tanaka Y., Shirai D., Miyazaki M., Imai N., Yokokawa T., Okada M., Kubori S. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients. Nephron. 1992;61(2):132–134. doi: 10.1159/000186859. [DOI] [PubMed] [Google Scholar]
  25. Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S. C., Dinarello C. A. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 1990 Jan 1;75(1):40–47. [PubMed] [Google Scholar]
  26. Topley N., Brown Z., Jörres A., Westwick J., Davies M., Coles G. A., Williams J. D. Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. Am J Pathol. 1993 Jun;142(6):1876–1886. [PMC free article] [PubMed] [Google Scholar]
  27. Topley N., Jörres A., Luttmann W., Petersen M. M., Lang M. J., Thierauch K. H., Müller C., Coles G. A., Davies M., Williams J. D. Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha. Kidney Int. 1993 Jan;43(1):226–233. doi: 10.1038/ki.1993.36. [DOI] [PubMed] [Google Scholar]
  28. Zanetti G., Heumann D., Gérain J., Kohler J., Abbet P., Barras C., Lucas R., Glauser M. P., Baumgartner J. D. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide. J Immunol. 1992 Mar 15;148(6):1890–1897. [PubMed] [Google Scholar]
  29. Zemel D., ten Berge R. J., Struijk D. G., Bloemena E., Koomen G. C., Krediet R. T. Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane. Clin Nephrol. 1992 Feb;37(2):97–103. [PubMed] [Google Scholar]
  30. Zeni F., Tardy B., Vindimian M., Comtet C., Page Y., Cusey I., Bertrand J. C. High levels of tumor necrosis factor-alpha and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis. Clin Infect Dis. 1993 Aug;17(2):218–223. doi: 10.1093/clinids/17.2.218. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES